Cargando…

Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER‐based analysis of 15,836 cases

BACKGROUND: Primary tumor resection (PTR) as a treatment option for patients with stage IV pancreatic cancer (PC) is controversial. PATIENTS AND METHODS: Stage IV PC patients, with treatment data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER), were scree...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Ningzhen, Jiang, Yu, Weng, Yuanchi, Chen, Hao, Deng, Xiaxing, Shen, Baiyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419755/ https://www.ncbi.nlm.nih.gov/pubmed/34288562 http://dx.doi.org/10.1002/cam4.4147

Ejemplares similares

Oncological outcomes of robotic-assisted versus open pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a propensity score-matched analysis
por: Weng, Yuanchi, et al.
Publicado: (2020)

TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy
por: Zhai, Shuyu, et al.
Publicado: (2019)

Accuracy of Nodal Positivity in Inadequate Lymphadenectomy in Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Population Study Using the US SEER Database
por: Wang, Weishen, et al.
Publicado: (2019)

Identification of EMT-related alternative splicing event of TMC7 to promote invasion and migration of pancreatic cancer
por: Weng, Yuanchi, et al.
Publicado: (2023)

Higher body mass index indicated better overall survival in pancreatic ductal adenocarcinoma patients: a real-world study of 2010 patients
por: Fu, Ningzhen, et al.
Publicado: (2021)

miR-934 as a Prognostic Marker Facilitates Cell Proliferation and Migration of Pancreatic Tumor by Targeting PROX1
por: Jin, Yangbing, et al.
Publicado: (2020)

Robotic-assisted versus open distal pancreatectomy for benign and low-grade malignant pancreatic tumors: a propensity score-matched study
por: Weng, Yuanchi, et al.
Publicado: (2020)

The impact of Omicron pandemic and COVID‐19 vaccination on the pancreatic adenocarcinoma patients
por: Fu, Ningzhen, et al.
Publicado: (2022)

Who could complete and benefit from the adjuvant chemotherapy regarding pancreatic ductal adenocarcinoma? A multivariate‐adjusted analysis at the pre‐adjuvant chemotherapy timing
por: Fu, Ningzhen, et al.
Publicado: (2022)

Does Pre-operative Biliary Drainage Influence Long-Term Survival in Patients With Obstructive Jaundice With Resectable Pancreatic Head Cancer?
por: Shen, Ziyun, et al.
Publicado: (2020)

PRPF40A as a potential diagnostic and prognostic marker is upregulated in pancreatic cancer tissues and cell lines: an integrated bioinformatics data analysis
por: Huo, Zhen, et al.
Publicado: (2019)

Comparison of Radical Antegrade Modular Pancreatosplenectomy with Standard Retrograde Pancreatosplenectomy for Left-Sided Pancreatic Cancer: A Meta-Analysis and Experience of a Single Center
por: Huo, Zhen, et al.
Publicado: (2019)

Radiotherapy improves the survival of patients with stage IV NSCLC: A propensity score matched analysis of the SEER database
por: Zhang, Rui, et al.
Publicado: (2018)

Real‐world implications of nonbiological factors with staging, clinical management, and prognostic prediction in pancreatic ductal adenocarcinoma
por: Wang, Chao, et al.
Publicado: (2022)

Systematic Review and Meta-Analysis of Pancreatic Amylase Value on Postoperative Day 1 After Pancreatic Resection to Predict Postoperative Pancreatic Fistula
por: Lu, Xiongxiong, et al.
Publicado: (2016)

A new enhanced recovery after surgery pathway for left-sided pancreatic cancer patients after distal pancreatectomy
por: Wang, Yue, et al.
Publicado: (2019)

Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study
por: Zhou, Huaqiang, et al.
Publicado: (2017)

Prognostic Analysis and Influencing Serum Biomarkers of Patients With Resectable Pancreatic Adenosquamous Cancer
por: Shi, Yusheng, et al.
Publicado: (2021)

TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinoma
por: Zhou, Yiran, et al.
Publicado: (2023)

Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection
por: Chen, Haoda, et al.
Publicado: (2021)

Pancreatic Resections in Renal Failure Patients: Is It Worth the Risk?
por: Norman, K. S., et al.
Publicado: (2014)

Resection of the primary tumor improves survival in patients with gastro‐entero‐pancreatic neuroendocrine neoplasms with liver metastases: A SEER‐based analysis
por: Zheng, Mengzhen, et al.
Publicado: (2019)

Construction and integrated analysis of a lncRNA-associated competing endogenous RNA network reveal functional lncRNAs in pancreatic cancer
por: Liu, Yuanbin, et al.
Publicado: (2020)

Postoperative hyperprogression disease of pancreatic ductal adenocarcinoma after curative resection: a retrospective cohort study
por: Zou, Siyi, et al.
Publicado: (2022)

Portal vein resection in advanced pancreatic adenocarcinoma: is it worth the risk?
por: Marsoner, Katharina, et al.
Publicado: (2016)

Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis
por: Sonbol, Mohamad Bassam, et al.
Publicado: (2022)

Predicting Selection Preference of Robotic Pancreaticoduodenectomy (RPD) in a Chinese Single Center Population: Development and Assessment of a New Predictive Nomogram
por: Huo, Zhen, et al.
Publicado: (2019)

836 Central Nervous System Infections Caused by Acinetobacter baumannii.
por: Kyrillos, Ramona, et al.
Publicado: (2014)

836. Coccidioidomycosis in the Central U.S. – A Retrospective Case Series
por: Scott, Brian M, et al.
Publicado: (2023)

Tumor copy number instability is a significant predictor for late recurrence after radical surgery of pancreatic ductal adenocarcinoma
por: Wen, Chenlei, et al.
Publicado: (2020)

Survival benefit of surgical resection for stage IV gastric cancer: A SEER-based propensity score-matched analysis
por: Sun, Jianhui, et al.
Publicado: (2022)

Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature
por: Venderbosch, Sabine, et al.
Publicado: (2011)

Chemoradiotherapy vs radiotherapy for nonoperative early stage esophageal cancer: A seer data analysis
por: Li, Jiaxin, et al.
Publicado: (2020)

Associations between initiating antihypertensive regimens on stage I–III colorectal cancer outcomes: A Medicare SEER cohort analysis
por: Balkrishnan, Rajesh, et al.
Publicado: (2021)

Short-term Outcomes After Robot-Assisted vs Open Pancreaticoduodenectomy After the Learning Curve
por: Shi, Yusheng, et al.
Publicado: (2020)

Treatment of advanced gallbladder cancer: A SEER‐based study
por: Mao, Weipu, et al.
Publicado: (2019)

Identification of a lncRNA based signature for pancreatic cancer survival to predict immune landscape and potential therapeutic drugs
por: Ma, Di, et al.
Publicado: (2022)

A novel prognostic risk score model based on immune-related genes in patients with stage IV colorectal cancer
por: Xu, Ke, et al.
Publicado: (2020)

The impact of socioeconomic status on survival in stage III colon cancer patients: A retrospective cohort study using the SEER census‐tract dataset
por: Dhahri, Amina, et al.
Publicado: (2021)

Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I‐II or unresected stage III pancreatic cancer
por: Ma, Sung J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2dnsbneckddj97j8umvglm8u3n